Epidemiology of neurofibromatosis type 1.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  American journal of medical genetics

• Publication date

  1999-03-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8PMID 10469430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurofibromatosis-1: a maximum likelihood estimation of mutation rate

  2004cited by this paper
• Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes

  2004cited by this paper
• A large polymorphic repeat in the pericentromeric region of human chromosome 15q contains three partial gene duplications.

  1998cited by this paper
• Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dysmorphic features and developmental delay

  1998cited by this paper
• A prospective 10 year follow up study of patients with neurofibromatosis type 1

  1998cited by this paper
• Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients.

  1997cited by this paper
• Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population

  1997cited by this paper
• Risk of malignancy and death in neurofibromatosis.

  1997cited by this paper
• Paternal age and sporadic neurofibromatosis 1: A case‐control study and consideration of the methodologic issues

  1997cited by this paper
• Homonucleotide tracts, short repeats and CpG/CpNpG motifs are frequent sites for heterogeneous mutations in the neurofibromatosis type 1 (NF1) tumour-suppressor gene.

  1997cited by this paper
• Identification of de novo deletions at the NF1 gene: no preferential paternal origin and phenotypic analysis of patients

  1997cited by this paper
• Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion

  1997cited by this paper
• An Association Between Optic Glioma and Other Tumours of the Central Nervous System in Neurofibromatosis Type 1

  1997cited by this paper
• The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.

  1997cited by this paper
• De novo rearrangements found in 2% of index patients with spinal muscular atrophy: mutational mechanisms, parental origin, mutation rate, and implications for genetic counseling.

  1997cited by this paper
• Molecular genetics of neurofibromatosis type 1 (NF1).

  1996cited by this paper
• Exclusive paternal origin of new mutations in Apert syndrome

  1996cited by this paper
• Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients

  1996cited by this paper
• Neurofibromatosis Type 1—An Update and Review for the Primary Pediatrician

  1996cited by this paper
• Usefulness of screening investigations in neurofibromatosis type 1. A study of 152 patients.

  1996cited by this paper
• Molecular characterization of the breakpoints of a 12-kb deletion in the NF1 gene in a family showing germ-line mosaicism.

  1995cited by this paper
• Identification of neurofibromatosis 1 (NF1) homologous loci by direct sequencing, fluorescence in situ hybridization, and PCR amplification of somatic cell hybrids.

  1995cited by this paper
• Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden.

  1995cited by this paper
• Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father.

  1994cited by this paper
• Clinical manifestations of neurofibromatosis-1 in Chinese children.

  1994cited by this paper
• Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues.

  1994cited by this paper
• Molecular basis of neurofibromatosis type 1 (NF1): Mutation analysis and polymorphisms in the NF1 gene

  1994cited by this paper
• Parental origin of germ-line and somatic mutations in the retinoblastoma gene

  1994cited by this paper
• Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

  1994cited by this paper
• Parent-of-origin effects in multiple endocrine neoplasia type 2B.

  1994cited by this paper
• Neurofibromatosis type I (NFI) in Israeli families: linkage analysis as a diagnostic tool.

  1994cited by this paper
• Quantification of the paternal allele bias for new germline mutations in the retinoblastoma gene

  1994cited by this paper
• National Neurofibromatosis Foundation International Database.

  1993cited by this paper
• Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects

  1993cited by this paper
• Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1)

  1993cited by this paper
• Neurofibromatosis: Phenotype, Natural History and Pathogenesis

  1993cited by this paper
• Origin of the de novo duplication in Charcot-Marie-Tooth disease type 1A: unequal nonsister chromatid exchange during spermatogenesis.

  1993cited by this paper
• Neurofibromatosis Type 1: Review of the First 200 Patients in an Australian Clinic

  1993cited by this paper
• Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF-1)

  1993cited by this paper
• Detection of a neurofibromatosis type I (NF1) homologous sequence by PCR: implications for the diagnosis and screening of genetic diseases.

  1993cited by this paper
• Origin of mutation in sporadic cases of haemophilia‐B

  1992cited by this paper
• Heart disease: A textbook of cardiovascular medicine

  1992cited by this paper
• Genetics of neurofibromatosis 1 in Japan: mutation rate and paternal age effect

  1992cited by this paper
• NF1-related locus on chromosome 15.

  1992cited by this paper
• Diagnostic outcome in children with multiple café au lait spots.

  1992cited by this paper
• Mechanisms of insertional mutagenesis in human genes causing genetic disease

  1991cited by this paper
• Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment

  1991cited by this paper
• [Neurofibromatosis Type 1: genetic studies with DNA markers in 38 families].

  1991cited by this paper
• Paternal origin of new mutations in Von Recklinghausen neurofibromatosis

  1990cited by this paper
• Segregation analysis of peripheral neurofibromatosis (NF1).

  1990cited by this paper
• Tuberous sclerosis and neurofibromatosis : epidemiology, pathophysiology, biology, and management : proceedings of the International Symposium on Neurocutaneous Syndrome, 17-19 October 1989, Tokyo, Japan

  1990cited by this paper
• Somatostatin‐producing duodenal carcinoids in patients with von recklinghausen's neurofibromatosis. A predilection for black patients

  1990cited by this paper
• Diagnosis of neurofibromatosis I by using tightly linked, flanking DNA markers.

  1990cited by this paper
• Neurofibromatosis in Gothenburg, Sweden. I. Background, study design and epidemiology.

  1989cited by this paper
• Progress towards identifying the neurofibromatosis (NF1) gene.

  1989cited by this paper
• Genetic linkage mapping of chromosome 17 markers and neurofibromatosis type I.

  1989cited by this paper
• A genetic study of von Recklinghausen neurofibromatosis in south east Wales. II. Guidelines for genetic counselling.

  1989cited by this paper
• Prevalence of von Recklinghausen neurofibromatosis in Dunedin, New Zealand.

  1989cited by this paper
• Neurofibromatosis in Gothenburg, Sweden. IV. Genetic analyses.

  1989cited by this paper
• A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity.

  1989cited by this paper
• The diagnosis of neurofibromatosis-1 in the child under the age of 6 years.

  1989cited by this paper
• Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales.

  1988cited by this paper
• Von Recklinghausen neurofibromatosis: a clinical and population study in south-east Wales

  1988cited by this paper
• Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

  1988cited by this paper
• Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants.

  1988cited by this paper
• Genetic linkage studies of chromosome 17 RFLPs in von Recklinghausen neurofibromatosis (NF1).

  1987cited by this paper
• Long-term follow-up of von Recklinghausen neurofibromatosis. Survival and malignant neoplasms.

  1986cited by this paper
• On the Natural History of von Recklinghausen Neurofibromatosis

  1986cited by this paper
• The pathophysiology of neurofibromatosis: IX. Paternal age as a factor in the origin of new mutations.

  1984cited by this paper
• Linkage analysis of neurofibromatosis (von Recklinghausen disease).

  1983cited by this paper
• Raynaud phenomenon.

  1983cited by this paper
• Neurofibromatosis. A clinical and genetic study of 96 cases in Gothenburg, Sweden.

  1981cited by this paper
• Von Recklinghausen neurofibromatosis.

  1981cited by this paper
• Penetrance and variability in neurofibromatosis: a genetic study of 60 families.

  1979cited by this paper
• Molecular basis of base substitution hotspots in Escherichia coli

  1978cited by this paper
• On the mutation rate of neurofibromatosis

  1975cited by this paper
• Von Recklinghausen's Disease: A Clinicopathological Study

  1972cited by this paper
• A clinical, pathological, and genetic study of multiple neurofibromatosis

  1956cited by this paper

• Utilization of PET/MR Imaging and PET/CT in Uncommon Pediatric Disease.

  2026cites this paper
• Precision restoration of complex cervical instability and decompression for neurofibromatosis type I: a case report using patient-specific 3D-printed templates.

  2026cites this paper
• TGFβ-dependent signaling drives tumor growth and aberrant extracellular matrix dynamics in NF1-associated plexiform neurofibroma

  2025cites this paper
• Retrospective Analysis of Pediatric Optic Pathway Gliomas: Impact of NF1 Status on Visual and Structural Outcomes.

  2025cites this paper
• NELL2-PAX7 Transcriptional Cascade Suggests Activation Mechanism for RAD52-Dependent Alternative Lengthening of Telomeres During Malignant Transformation of Malignant Peripheral Nerve Sheath Tumors: Elongation of Telomeres and Poor Survival

  2025cites this paper
• Treatment of Plexiform Neurofibromas : Current Perspectives on Surgery and Medical Treatment

  2025cites this paper
• Temporomandibular joint ankylosis following bimaxillary surgery in a patient with neurofibromatosis type 1: a case report

  2025cites this paper
• A Rare twist: Case report of pediatric colo-colonic intussusception secondary to colonic schwannoma

  2025cites this paper
• Trapped in Silence: Severe Catatonia From Anti-N-Methyl-D-Aspartate (NMDA) Receptor Encephalitis in a Neurofibromatosis Type 1 Patient With Craniopharyngioma

  2025cites this paper
• Treatment of giant encephalocele and occipital defect in a child with neurofibromatosis type 1: illustrative case

  2025cites this paper
• Ataluren‐Induced Functional Restoration of Neurofibromin in Fibroblasts From Neurofibromatosis Type 1 Patients With Nonsense Mutations

  2025cites this paper
• Selumetinib use as targeted therapy for plexiform neurofibroma: a comprehensive review of the literature

  2025cites this paper
• Early experience with renal autotransplant for renal artery stenosis in a 6-year-old patient with neurofibromatosis type 1: a case report

  2025cites this paper
• ‘Alone on our NF1 island’: a patient-led mixed-method survey study to understand the care pathway for neurofibromatosis type 1 (NF1) patients in the UK

  2025cites this paper
• Unraveling the molecular landscape of congenital pseudoarthrosis of the tibia: insights from a comprehensive analysis of 159 probands

  2025cites this paper
• Gender-Specific Fine Motor Skill Learning Is Impaired by Myelin-Targeted Neurofibromatosis Type 1 Gene Mutation

  2024cites this paper
• Feasibility and acceptability of a telehealth intervention for improving peer relationships for adolescents with neurofibromatosis type 1: a single-arm pilot study.

  2024cites this paper
• Neurofibromatosis and its Unusual Variants with Clinical and Histopathological Correlation - A Study in a Tertiary Care Centre

  2024cites this paper
• Hereditary Syndromes Associated with Brain Tumors. Literature Review.

  2024cites this paper
• Neurofibromatosis Type 1, Case Report of Surgical Treatment of Cervical C2 Kissing Neurofibromas

  2024cites this paper
• Pain Related Quality of Life in Neurofibromatosis Type 1: A Narrative Review

  2024cites this paper
• Long-term distress throughout one’s life: health-related quality of life, economic and caregiver burden of patients with neurofibromatosis type 1 in China

  2024cites this paper
• Glioblastoma multiforme in a patient with neurofibromatosis type 1: a case report and review of literature

  2024cites this paper
• A review neurofibromatosis type 1: Quality of life of children and adolescents

  2024influential citation
• Whole-body MRI-based long-term evaluation of pediatric NF1 patients without initial tumor burden with evidence of newly developed peripheral nerve sheath tumors

  2024cites this paper
• Rare genetic interstitial lung diseases: a pictorial essay

  2024cites this paper
• NF2 with NF1 Features a Unique Overlap

  2024cites this paper
• snRNA-seq of human cutaneous neurofibromas before and after selumetinib treatment implicates role of altered Schwann cell states, inter-cellular signaling, and extracellular matrix in treatment response

  2024cites this paper
• TSPO deficiency promotes the progression of malignant peripheral sheath tumors by regulating the G2/M phase of the cell cycle via CDK1

  2024cites this paper
• Investigating therapeutic nonsense suppression in a neurofibromatosis mouse model.

  2024cites this paper
• The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation

  2024cites this paper
• Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers

  2023cites this paper
• Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.

  2023cites this paper
• The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial

  2023cites this paper
• Evaluation of Molecular and Clinical Findings in Children With Neurofibromatosis Type 1: Identification of 15 Novel Variants.

  2023cites this paper
• The role of unidentified bright objects in the neurocognitive profile of neurofibromatosis type 1 children: a volumetric MRI analysis

  2023cites this paper
• Econazole selectively induces cell death in NF1-homozygous mutant tumor cells

  2023cites this paper
• Unraveling the Molecular Landscape of Congenital Pseudoarthrosis of the Tibia: Insights from a Comprehensive Analysis of 162 Probands

  2023cites this paper
• Combined CDK4/6 and ERK1/2 inhibition enhances anti-tumor activity in NF1-associated plexiform neurofibroma.

  2023cites this paper
• Genetic evaluation of 50 Turkish patients with neurofibromatosis type 1: 2 years experience of a single center

  2023cites this paper
• Olfactory groove monophasic sinovial sarcoma and von Recklinghausen’s disease: A case report and literature review

  2023influential citation
• Preimplantation genetic testing for Neurofibromatosis type 1: more than 20 years of clinical experience

  2023cites this paper
• Humanization for neurological disease modeling: A roadmap to increase the potential of Drosophila model systems

  2023cites this paper
• Use of Expandable Corpectomy Trial and Cage for Reduction of Neurofibromatosis Associated Cervical Swan Neck Deformity

  2023cites this paper
• Seizure freedom with vagus nerve stimulation in neurofibromatosis type 1: A case report

  2023cites this paper
• Neurofibromatosis Type 1: Pediatric Aspects and Review of Genotype–Phenotype Correlations

  2023cites this paper
• A novel stop-gain NF1 variant in neurofibromatosis type 1 and bilateral optic atrophy without optic gliomas

  2023cites this paper
• Analysis of the current Covid-19 infection and vaccination status in patients with neurofibromatosis type 1

  2023cites this paper
• A new era for myelin research in Neurofibromatosis type 1

  2023cites this paper
• Mediastinal Teratoma Mimicking Neurofibroma in CT-Guided Biopsy in a Patient With Neurofibromatosis Type 1

  2023cites this paper
• Role of nerves in neurofibromatosis type 1-related nervous system tumors.

  2022cites this paper
• An Intrathoracic Meningocele in a Neurofibromatosis Type I Patient Mimicking Severe COVID-19 Disease

  2022cites this paper
• Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development

  2022cites this paper
• Spontaneous Pneumothorax: A Rare Complication of Neurofibromatosis Type 1 Associated Diffuse Lung Disease

  2022cites this paper
• The Epidemiology of Central Nervous System Tumors.

  2022cites this paper
• Functional restoration of mouse Nf1 nonsense alleles in differentiated cultured neurons

  2022cites this paper
• CASE SERIES

  2022cites this paper
• Burden Among Caregivers of Pediatric Patients with Neurofibromatosis Type 1 (NF1) and Plexiform Neurofibroma (PN) in the United States: A Cross-Sectional Study

  2022cites this paper
• A Systematic Review of Recent and Ongoing Clinical Trials in Patients With the Neurofibromatoses.

  2022cites this paper
• Bibliometric analysis of the top 100 most-cited articles in neurofibromatosis

  2022cites this paper
• The Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase Pathway in Osteoblasts

  2022cites this paper
• Visual outcomes and predictors in optic pathway glioma: a single centre study

  2022cites this paper
• Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1

  2022cites this paper
• Ischemic stroke with extensive vasculopathy in a patient with neurofibromatosis type 1

  2022cites this paper
• A novel HDAC11 inhibitor potentiates the tumoricidal effects of cordycepin against malignant peripheral nerve sheath tumor through the Hippo signaling pathway.

  2022cites this paper
• Social behavior in RASopathies and idiopathic autism

  2022cites this paper
• Experimental models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor

  2022cites this paper
• Circular RNA_0061,587 is associated with the tumorigenesis of neurofibromatosis type 1.

  2022cites this paper
• Diagnostic value of 18F-FDG PET-CT in detecting malignant peripheral nerve sheath tumors among adult and pediatric neurofibromatosis type 1 patients

  2022cites this paper
• Virtual Reality Water Maze Navigation in Children with Neurofibromatosis Type 1 and Reading Disability: an Exploratory Study

  2022cites this paper
• Sphenoid dysplasia in patients with neurofibromatosis type 1: Clinical features and imaging findings including cerebrospinal fluid alterations.

  2022cites this paper
• Current concepts of neurofibromatosis type 1: pathophysiology and treatment

  2022cites this paper
• Baseline characteristics of adults with neurofibromatosis enrolled on a psychosocial randomized controlled trial

  2022cites this paper
• Fatal Retroperitoneal Bleeding in Neurofibromatosis Type 1

  2022cites this paper
• Human induced pluripotent stem cell modeling of neurofibromatosis type 1

  2022cites this paper
• A Case of Duodenal Neuroendocrine Tumor Accompanied by Gastrointestinal Stromal Tumors in Type 1 Neurofibromatosis Complicated by Life-Threatening Vascular Lesions.

  2021cites this paper
• Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

  2021cites this paper
• Orthopaedic manifestations of neurofibromatosis type 1: A case report

  2021cites this paper
• Pediatric Glioma: An Update of Diagnosis, Biology, and Treatment

  2021cites this paper
• Multiple epistatic DNA variants in a single gene affect gene expression in trans.

  2021cites this paper
• Targeted Therapies for the Neurofibromatoses

  2021cites this paper
• NEUROFIBROMATOSIS OF AN ISOLATED FOOT: A CASE REPORT

  2021cites this paper
• Case Report Incidentally detected pituitary macroadenoma in a case of neurofibromatosis type 1: A case report and review of literature

  2021cites this paper
• Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations

  2021cites this paper
• Different Pathology of Peripheral Nerve Sheath Tumor in Neurofibromatosis Type 1: 3 Cases

  2021cites this paper
• Whole-body MRI evaluation in neurofibromatosis type 1 patients younger than 3 years old and the genetic contribution to disease progression

  2021cites this paper
• Acceptance and commitment therapy for adolescents and adults with neurofibromatosis Type 1, plexiform neurofibromas, and chronic pain: Results of a randomized controlled trial

  2021cites this paper
• Alterations in brain morphology by MRI in adults with neurofibromatosis 1

  2021cites this paper
• A Large Intrathoracic Mass in A Patient With Neurofibromatosis Type 1

  2021cites this paper
• SUZ12 Loss Amplifies the Ras/ERK Pathway by Activating Adenylate Cyclase 1 in NF1-Associated Neurofibromas

  2021cites this paper
• US Food and Drug Administration regulatory updates in neuro-oncology

  2021cites this paper
• A Tale of Two Organ Systems: Imaging Review of Diseases Affecting the Thoracic and Neurological Systems. Part 2.

  2021cites this paper
• Effects of Age on White Matter Microstructure in Children With Neurofibromatosis Type 1

  2021cites this paper
• Association between pectus excavatum and congenital genetic disorders: A systematic review and practical guide for the treating physician: pectus excavatum and congenital genetic disorders.

  2021cites this paper
• Novel molecular targeted therapies for patients with neurofibromatosis type 1 with inoperable plexiform neurofibromas: a comprehensive review

  2021cites this paper
• White matter is increased in the brains of adults with neurofibromatosis 1

  2021cites this paper
• New cellular models of undifferentiated pleomorphic sarcoma and malignant peripheral nerve sheath tumor

  2021cites this paper
• Deep Vein Thrombosis in the Setting of Neurofibromatosis Type 1: Case Report

  2021cites this paper
• Association between pheochromocytoma and neurofibromatosis type I: a rare entity in the African population

  2021cites this paper
• The Phakomatoses

  2021cites this paper